Citation Impact
Citing Papers
Biomedically-relevant metal organic framework-hydrogel composites
2023 StandoutNobel
Microneedle arrays as transdermal and intradermal drug delivery systems: Materials science, manufacture and commercial development
2016
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Does nicotinic acid (niacin) lower blood pressure?
2008
Acceptance and Opinions of Intanza/IDflu Intradermal Influenza Vaccine in the Czech Republic and Turkey
2012
Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis
2014 Standout
Metabolism and Excretion of Anacetrapib, a Novel Inhibitor of the Cholesteryl Ester Transfer Protein, in Humans
2009
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Arrestin Development: Emerging Roles for β-arrestins in Developmental Signaling Pathways
2009 StandoutNobel
Nicotinic acid: an old drug with a promising future
2007
Attitudes to vaccination: A critical review
2014 Standout
Niacin and fibrates in atherogenic dyslipidemia: Pharmacotherapy to reduce cardiovascular risk
2010
Therapeutic potential of β-arrestin- and G protein-biased agonists
2010 StandoutNobel
Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling
2011 StandoutNobel
Update on strategies to increase HDL quantity and function
2009
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
2010 Standout
Teaching old receptors new tricks: biasing seven-transmembrane receptors
2010 StandoutNobel
β-Arrestin1 mediates nicotinic acid–induced flushing, but not its antilipolytic effect, in mice
2009 StandoutNobel
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Microneedles for drug and vaccine delivery
2012 Standout
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
2011 Standout
Bioactive Benzofuran derivatives: A review
2014
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
G Protein-Coupled Receptor 119 (GPR119) Agonists for the Treatment of Diabetes: Recent Progress and Prevailing Challenges
2015
Update on the Discovery and Development of Cholesteryl Ester Transfer Protein Inhibitors for Reducing Residual Cardiovascular Risk
2013
Perspectives on low-density lipoprotein cholesterol goal achievement
2008
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A
2011 StandoutNobel
Guidelines for the Primary Prevention of Stroke
2014 Standout
Lipoprotein(a) Is Associated Differentially With Carotid Stenosis, Occlusion, and Total Plaque Area
2008
Nicotinic Acid: Pharmacological Effects and Mechanisms of Action
2007
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
2011
Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box
2015 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Vaccines: the Fourth Century
2009
Works of Eva Vets being referenced
Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults
2008
Assessment of the CYP3A‐Mediated Drug Interaction Potential of Anacetrapib, a Potent Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Healthy Volunteers
2008
Suppression of Niacin-induced Vasodilation with an Antagonist to Prostaglandin D2 Receptor Subtype 1
2007
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of JNJ-38431055, a Novel GPR119 Receptor Agonist and Potential Antidiabetes Agent, in Healthy Male Subjects
2011